Cite

HARVARD Citation

    Kassie, F. et al. (2022). Combinatory lung tumor inhibition by myo-inositol and iloprost/rapamycin: association with immunomodulation. Carcinogenesis. pp. 547-556. [Online]. 
  
Back to record